🇺🇸 FDA
Pipeline program

ONC206

200814

Phase 1 small_molecule active

Quick answer

ONC206 for Diffuse Midline Glioma (DMG) is a Phase 1 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).

Program details

Company
Jazz Pharmaceuticals plc
Indication
Diffuse Midline Glioma (DMG)
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials